Study S001706

Tailored Exercise Training Study Among Adults With HFpEF

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07223242
Acronym: TEXPEF
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2; PHASE3
Masking: NONE
Status: RECRUITING
Enrollment: 120
Start: 2025-02-18
Primary completion: 2026-12-30
Lead sponsor: University of Texas Southwestern Medical Center
Conditions: HFpEF - Heart Failure With Preserved Ejection Fraction; Diabetic Cardiomyopathies
Interventions: BEHAVIORAL:Moderate-intensity continuous training (MCT); BEHAVIORAL:Resistance training; DRUG:Weight loss
Results posted: FALSE

Registered primary outcomes

Peak Exercise Oxygen Uptake (VO2peak) [Baseline, 3months, 6months, and 9months]
Short Physical Performance Battery (SPPB) [Baseline, 3months, 6months, and 9months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.